FDA Inspection 847151 — Aurobindo Pharma Limited
The FDA completed an inspection of Aurobindo Pharma Limited on Aug 16, 2013 in Medchal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 16, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Medchal (India)